A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

NCT06074562 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Peripheral Neuropathy

Interventions

DRUG: LY3556050
DRUG: Placebo

Sponsor

Eli Lilly and Company